Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 DiabetesRury R. Holman, Adrian F. Hernandez, M. Angelyn Bethel et al.|New England Journal of Medicine|2017Cited by 2.1k
A variant in CDKAL1 influences insulin response and risk of type 2 diabetesValgerður Steinthórsdóttir, Kāri Stefánsson, Guðmar Þorleifsson et al.|Nature Genetics|2007Cited by 1.1k
Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United StatesRonald C.W., Juliana C.N. Chan|Annals of the New York Academy of Sciences|2013Cited by 813
Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysisM. Angelyn Bethel, Rury R. Holman, Rishi Patel et al.|The Lancet Diabetes & Endocrinology|2017Cited by 591
Identification of type 2 diabetes loci in 433,540 East Asian individualsCassandra N. Spracklen, Annie-Green Howard, Donald W. Bowden et al.|Nature|2020Cited by 460